JIWON CHOI

• Managed the preparation, handling, and documentation of investigational medicinal products (IMPs) in oncology clinical trials, including aseptic reconstitution and dilution of injectable chemotherapy drugs.
• Collaborated closely with principal investigators, Clinical Research Coordinators (CRCs), and nursing staff to ensure seamless coordination from prescription to administration, maintaining a focus on patient safety and protocol adherence.
• Provided detailed medication counseling to trial participants, ensuring understanding of administration protocols, potential side effects, and adherence requirements.
• Successfully supported two audits during the trial phase by responding to auditor inquiries and ensuring that all documentation and processes met regulatory standards.
• Played a key role in the initiation of new clinical trials, contributing to the setup of electronic prescription systems and the selection of pre-medication regimens for managing adverse effects.
• Monitored and ensured compliance with trial protocols, contributing to the successful and compliant completion of clinical studies

[Drug safety Monitoring Center]

• Evaluated adverse drug responses and monitored poly-pharmacy cases, contributing to patient safety.
• Optimized medication safety by providing thorough drug information to healthcare providers.
• Undertook research projects to advance knowledge in adverse drug responses related to immune system. (Case report: A Case of Atypical Fixed Drug Eruption Induced by Erdosteine)

[Oncology pharmacy services]

• Increased patient satisfaction by providing in-depth counseling on medications and proper usage of medication.

[Pediatric pharmacy services]

• Provided expert consultation to healthcare providers on Total Parenteral Nutrition (TPN), addressing individual patient needs and medical conditions.